• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchVeru
    Picture of Veru logo

    VERU — Veru Share News

    $2.240.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    • Market Cap
      $38.19m
    • Enterprise Value
      $12.40m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • VERU Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    VERU Dividends
    • Drug developer Veru falls on bigger Q2 loss

      11/05/2023 20:07
    • Veru Inc reports results for the quarter ended in March - Earnings Summary

      11/05/2023 14:31
    • Brief: Veru Reports Fiscal 2023 Q2 Financial Results

      11/05/2023 13:17
    • Brief: Veru Q2 revenue USD 6.6 million

      11/05/2023 12:20
    • Veru Inc expected to post a loss of 33 cents a share - Earnings Preview

      09/05/2023 19:30
    • Brief: Veru Reaches Agreement With FDA On Confirmatory Phase 3 Clinical Trial

      04/05/2023 13:41
    • Brief: Veru Inc Files For Offering Of Up To $100 Million Of Shares Of Common Stock

      03/05/2023 17:37
    • Brief: Veru Enters Into Common Stock Purchase Agreement For Up To $100 Million With Lincoln Park Capital

      03/05/2023 13:55
    • Veru rises on sale of prostrate disorder drug business

      20/04/2023 12:52
    • Brief: Veru Sells Entadfi Business For $20 Million Plus Up To An Additional $80 Million From Sales Milestones

      20/04/2023 12:41
    • Brief: Veru Enters Into Supply Agreement With Afaxys To Expand Access To Fc2 Female Condom® In U.S. Public Health Sector

      19/04/2023 13:35
    • Brief: Veru Inc Entered Into Stock Purchase Agreement With Frost Gamma Investments Trust

      13/04/2023 12:13
    • Veru up on positive poxviruses therapy data from preclinical study

      11/04/2023 17:47
    • Brief: Veru Announces Preclinical Study Results That Demonstrate Sabizabulin Inhibits Poxviruses

      11/04/2023 13:48
    • U.S. STOCKS ON THE MOVE-AMC Entertainment, Trilogy Metals, Nogin

      04/04/2023 19:14
    • U.S. STOCKS ON THE MOVE-Duckhorn Portfolio, BullFrog AI, VBI Vaccines

      04/04/2023 17:14
    • Veru gains on positive data for respiratory disease drug in animal study

      04/04/2023 14:02
    • Brief: Veru Inc Files For Mixed Shelf Of Up To $200 Mln

      16/03/2023 22:57
    • U.S. STOCKS ON THE MOVE-Jack Henry, Coty, Netflix

      15/03/2023 17:58
    • U.S. STOCKS ON THE MOVE-Boeing, Alcoa, Canadian Pacific

      15/03/2023 16:14
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.